Background Relapsed or refractory classic Hodgkin lymphoma (RRcHL) associates with poor prognosis and heavy disease … conventional chemotherapy in treating relapsed or refractory classic Hodgkin lymphoma in China, with the ICER under a conventional … refractory classic Hodgkin lymphoma in China. Highlights • In China, BV was approved in 2020 for the treatment of adult patients …